KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Long-Term Investments: 2009-2012

Historic Long-Term Investments for Teva Pharmaceutical Industries (TEVA) over the last 4 years, with Sep 2012 value amounting to -$164.0 million.

  • Teva Pharmaceutical Industries' Long-Term Investments fell 1540.00% to -$164.0 million in Q3 2012 from the same period last year, while for Sep 2012 it was -$164.0 million, marking a year-over-year decrease of 1540.00%. This contributed to the annual value of $991.0 million for FY2011, which is 56.80% up from last year.
  • According to the latest figures from Q3 2012, Teva Pharmaceutical Industries' Long-Term Investments is -$164.0 million, which was down 47.75% from -$111.0 million recorded in Q2 2012.
  • In the past 5 years, Teva Pharmaceutical Industries' Long-Term Investments registered a high of $1.0 billion during Q1 2012, and its lowest value of -$164.0 million during Q3 2012.
  • Moreover, its 3-year median value for Long-Term Investments was $632.0 million (2010), whereas its average is $456.7 million.
  • In the last 5 years, Teva Pharmaceutical Industries' Long-Term Investments surged by 63.79% in 2010 and then slumped by 5,450.00% in 2012.
  • Quarterly analysis of 4 years shows Teva Pharmaceutical Industries' Long-Term Investments stood at $534.0 million in 2009, then grew by 18.35% to $632.0 million in 2010, then soared by 56.80% to $991.0 million in 2011, then crashed by 1,540.00% to -$164.0 million in 2012.
  • Its Long-Term Investments stands at -$164.0 million for Q3 2012, versus -$111.0 million for Q2 2012 and $1.0 billion for Q1 2012.